Pzena Investment Management Llc
Source: SEC Form 13F · as of Mar 2026Pzena Investment Management Llc holds 12 biotech & pharma companies tracked by BioSniper, totaling $2.76B in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$2.76B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Baxter International Inc. (BAX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BAXBaxter International Inc. | 64,527,823 | $1.08B |
| BMYBRISTOL MYERS SQUIBB CO | 17,095,731 | $1.04B |
| FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) | 15,052,822 | $339.6M |
| PFEPFIZER INC | 5,924,892 | $166.4M |
| ELVElevance Health Inc. | 220,176 | $64.5M |
| JNJJOHNSON & JOHNSON | 203,965 | $49.9M |
| USNAUSANA HEALTH SCIENCES INC | 1,108,933 | $19.4M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 18,823 | $1.0M |
| SNYSanofi | 19,088 | $920K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 28,360 | $525K |
| MRKMerck & Co., Inc. | 2,511 | $302K |
| HALOHALOZYME THERAPEUTICS, INC. | 4,049 | $262K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.